Prescription Transcription Error Leads to $140M Wrongful Death Verdict

|

An Alabama jury awarded $140 million last week in a wrongful death lawsuit over a prescription error that was allegedly caused by the outsourcing of medical transcription services. 

Sharron Juno died in March 2008, after receiving a fatal drug dose, which the jury blamed on both a transcription service in India and the hospital that gave her the prescription, Thomas Hospital in Baldwin County, Alabama.

According to allegations raised at trial during the wrongful death lawsuit, Thomas Hospital outsourced medical transcription services to a company that used workers in in Mumbai and New Delhi, India, who made errors that led to Juno’s death.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

The lawsuit claimed that the transcription service, which transcribed admission paperwork sent from the hospital to a rehabilitation facility to which Juno was being transferred, made three critical errors. The most serious of which was incorrectly transcribing the dosage of Levemir insulin as 80 units instead of the actual amount prescribed; eight.

As a result of the prescription error, Juno reportedly suffered severe brain damage due to a Levemir overdose, leading to cardiopulmonary arrest and ultimately to her death.

The lawsuit claimed Thomas Hospital failed to follow its own procedures by not reviewing or signing Juno’s Discharge Summary. According to a press release issued by Juno’s attorneys, it was also revealed at trial that U.S. employees of the transcription company had complained about the subcontractors at Medusind Solutions Inc. in Mumbai and Sam Tech Datasys in New Delhi, indicating that the companies’ work was shoddy and prone to errors.

According to a local medial report by WKRG.com, Thomas Hospital officials have indicated that they believe the $140 million verdict was an excessive judgment and plan to appeal.

Written by: Irvin Jackson

Senior Legal Journalist & Contributing Editor

Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends.

Image Credit: |



0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

A new lawsuit against Roblox alleges that the platform’s inadequate safety measures enabled multiple sexual predators to exploit a five-year-old girl.
Breast mesh implants promoted as internal bras are now under scrutiny, following studies and FDA warnings linking the devices to infections, implant loss, and surgical failure. Lawsuits are being investigated for women who suffered complications after reconstruction or augmentation procedures involving products like GalaFLEX, Phasix, Strattice, and AlloDerm.
Dupixent users are coming forward with accounts of devastating cancer diagnoses, saying the popular eczema drug masked early warning signs of cutaneous T-cell lymphoma. As the FDA investigates and the first lawsuit is filed, researchers warn Dupixent may unmask or accelerate hidden cancers, raising urgent questions about its long-term safety.